Patents Assigned to BioSpecifics Technologies LLC
  • Treatment of uterine fibroids using purified collagenase
    Patent number: 11872267
    Abstract: Disclosed herein are compositions and methods for treating uterine fibroids in vivo, and methods of reducing symptoms associated with uterine fibroids, including pain, bleeding and infertility. The disclosed compositions comprise collagenase in an amount effective to cause shrinkage and/or reduce stiffness of uterine fibroids.
    Type: Grant
    Filed: October 14, 2020
    Date of Patent: January 16, 2024
    Assignees: The Johns Hopkins University, Duke University, BioSpecifics Technologies LLC
    Inventors: James H. Segars, Phyllis Carolyn Leppert, Thomas L. Wegman, Jean-Marie Soma
  • Treatment method and product for uterine fibroids using purified collagenase
    Patent number: 11857685
    Abstract: Compositions and methods for treating uterine fibroids are described, wherein a uterine fibroid treatment agent comprising collagenase in an amount effective to cause shrinkage of uterine fibroids is injected or inserted into the uterine fibroid.
    Type: Grant
    Filed: April 5, 2021
    Date of Patent: January 2, 2024
    Assignees: BioSpecifics Technologies LLC, Duke University
    Inventors: Phyllis Carolyn Leppert, Thomas L. Wegman